Stallion India Fluorochemicals has delivered a robust performance for FY25–26, showing double-digit growth across key financial metrics despite a challenging global macro environment marked by energy volatility and supply-chain disruptions.
The company’s total revenue rose to Rs. 43,412.30 lakh, up 14.40% year-on-year, while profitability strengthened significantly.
EBITDA climbed 23.34% to Rs. 6,134.74 lakh, and PAT surged 35.61% to Rs. 4,384.11 lakh, underscoring improved operating efficiency and execution strength. Earnings per share increased 21.92% to Rs. 5.34.
Commenting on the results, Shazad Rustomji - Managing Director & CEO of Stallion India Fluorochemicals Limited, said: "We are pleased to report a resilient operational and financial performance for FY26 despite increasing volatility across global energy and supply-chain markets.
"During FY26, the Company reported Total Revenue of Rs. 434.12 crores, reflecting a YoY growth of 14.40%, while EBITDA increased by 23.34% to Rs. 61.35 crores and PAT increased by 35.61% to Rs. 43.84 crores, demonstrating the strength of our operating model and execution capabilities.
Despite the challenging external environment, the Company successfully achieved its targeted topline growth projection of approximately Rs. 430 crore, reflecting the resilience of our business model, operational agility, and strong customer relationships."
He added: "A key long-term growth driver for the Company remains the proposed 10,000 MT R-32 manufacturing facility at Bhilwara, Rajasthan, for which Environmental Clearance has already been received.
"The project strengthens backward integration, enhances supply-chain security, supports import substitution, and positions Stallion to capitalize on the growing transition toward low-GWP refrigerants. The R-32 project is progressing well and remains on track for commencement by October 2026.
"During FY26, we continued strengthening our position across high-growth industrial applications while expanding our specialty gas, semiconductor gas, helium, and HFO infrastructure. These strategic initiatives, along with backward integration into manufacturing, are expected to support our targeted revenue CAGR of 30–35% over the next 3 years while improving margins by 3–4%"
Beyond near-term earnings strength, the company is betting on structural expansion in high-growth industrial gases and specialty chemical segments. Investments in semiconductor gases, helium, and HFO infrastructure are being positioned as long-term margin and scale drivers.
A major focus remains the upcoming 10,000 MT R-32 manufacturing facility in Bhilwara, Rajasthan, which has already secured environmental clearance and is targeted for commissioning by October 2026. The project is expected to strengthen backward integration, reduce import dependence, and align the company with the global shift toward low-GWP refrigerants.
With management projecting a 30–35% revenue CAGR over the next three years and a 3–4% margin improvement, Stallion is positioning itself for an accelerated growth phase built on supply-chain resilience, capacity expansion, and specialty chemical demand tailwinds.
